How to Get GLP-1 Covered by Insurance: Step-by-Step

Getting insurance to cover GLP-1 medications for weight loss can feel like navigating a maze. Many plans exclude weight loss drugs, and even those that cover them often require prior authorization and extensive documentation. But with the right approach, many patients successfully get coverage. This step-by-step guide shows you exactly how to maximize your chances.

Step 1: Know Your Plan's Formulary

Before doing anything else, find out what your insurance plan actually covers. Call the number on your insurance card and ask specifically:

Does my plan cover medications for obesity or weight management?
Which specific GLP-1 medications are on the formulary? (Ask about Wegovy, Zepbound, Ozempic, and Mounjaro by name)
What tier are these medications on? (Lower tiers mean lower copays)
Is prior authorization required?
Are there any step therapy requirements? (Must try other medications first)
Is there a quantity limit?

Document every call: note the date, time, representative name, and reference number. This information is valuable if you need to appeal later.

Step 2: Get a Proper Diagnosis

Insurance companies are far more likely to approve GLP-1 medications when the prescription is tied to a recognized medical diagnosis with documented medical necessity. Ask your doctor to ensure your records include:

Obesity diagnosis (ICD-10 code E66.01) — For patients with BMI 30+
Overweight with comorbidity — For patients with BMI 27-29.9 plus diabetes, hypertension, dyslipidemia, or sleep apnea
Documentation of failed weight loss attempts — Many plans require evidence that diet and exercise alone were insufficient
Related comorbidity documentation — The more weight-related health conditions documented, the stronger the case

Step 3: Submit Prior Authorization

Most insurance plans require prior authorization (PA) for GLP-1 medications. Your doctor's office typically handles this, but you should be involved in the process. Provide your doctor with:

Your complete medical history related to weight and metabolic health
Records of previous weight loss attempts (Weight Watchers, Noom, medically supervised diets, etc.)
Documentation of weight-related health conditions
Lab results (HbA1c, lipid panel, liver function, fasting glucose)

The PA request should clearly articulate medical necessity, not just a desire to lose weight. Framing the request around treating obesity as a chronic disease with documented comorbidities significantly increases approval rates.

Step 4: If Denied, Appeal Immediately

Initial denials are common. According to industry data, approximately 30-40% of GLP-1 prior authorizations are denied on first submission. But here is the critical fact: a significant percentage of appeals are successful. Do not accept a denial as final.

When you receive a denial, immediately:

Request the denial in writing — The insurer must provide a specific reason for the denial
Review the denial reason carefully — Is it a formulary exclusion, insufficient documentation, or a medical necessity dispute?
File a Level 1 (internal) appeal within the deadline specified in the denial letter (usually 30-60 days)
Include a letter of medical necessity from your prescribing physician that directly addresses the denial reason
Include supporting clinical evidence — Reference the STEP trials, SELECT cardiovascular data, or relevant clinical guidelines

Step 5: Escalate If Necessary

If the internal appeal is denied, you have additional options:

External appeal — Request an independent medical review by a third party. This is your right under the Affordable Care Act for most plans.
State insurance commissioner complaint — If you believe the denial violates state parity laws or your plan's own coverage terms
Employer advocacy — If you have employer-sponsored insurance, your HR department or benefits administrator may be able to intervene, especially for large self-insured employers who have flexibility in plan design
Peer-to-peer review — Your doctor can request a conversation with the insurance company's medical director to discuss the case directly

Alternative Coverage Strategies

If your current plan definitively excludes weight loss medications, consider these alternatives:

Diabetes pathway: If you have type 2 diabetes or prediabetes, Ozempic and Mounjaro may be covered under the diabetes indication
Cardiovascular pathway: Wegovy now has an FDA indication for cardiovascular risk reduction. If you have established cardiovascular disease or high risk, this indication may provide a different coverage path
Plan switching during open enrollment: Research plans that include obesity medication coverage and switch during your next enrollment period
Manufacturer savings programs: Even with insurance, copay assistance cards can reduce out-of-pocket costs significantly
HSA/FSA funds: GLP-1 medications prescribed by a doctor typically qualify as eligible expenses for Health Savings Accounts and Flexible Spending Accounts

Documenting Everything

Throughout this entire process, keep meticulous records:

Copies of all submitted paperwork
Denial letters and appeal responses
Phone call logs with representative names and reference numbers
Letters of medical necessity from your provider
Supporting clinical literature you have referenced

This documentation is essential if you need to escalate to an external appeal or file a complaint with your state insurance commissioner.

The Bottom Line

Getting insurance coverage for GLP-1 medications requires persistence and strategy. Start by understanding your plan, work with your doctor to build the strongest possible case, and do not accept an initial denial as the final word. Many patients who are initially denied eventually get coverage through the appeal process. The effort is worth it when you consider the alternative of paying $1,000+ per month out of pocket.

For additional resources and community support on navigating GLP-1 costs and coverage, look for providers that offer dedicated insurance navigation support as part of their program.